Botulinum toxin type A in chronic non‐dyshidrotic palmar eczema: A side‐by‐side comparative study
- 14 April 2020
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (6), 601-608
- https://doi.org/10.1111/1346-8138.15344
Abstract
New indications are being reported for intradermal botulinum toxin type A (BTX‐A) owing to its anti‐inflammatory and antipruritic actions. Its successful use for dyshidrotic hand eczema and lichen simplex has been reported in a few cases, while its utility in dry palmar eczema not associated with hyperhidrosis has not yet been investigated. The aim of this study was the assessment of the additive efficacy and tolerability of BTX‐A in chronic dry palmar eczema. This prospective non‐randomized side‐by‐side comparative study included 30 cases of chronic bilateral dry palmar eczema with no associated hyperhidrosis. Combined emollients and topical mid‐potency steroid on one side were compared with an additive 100 units of intradermal BTX‐A on the other side for efficacy and tolerability using both patient‐ and physician‐oriented scores over a period of 6 months. Timing and extent of improvement and relapse were recorded on both sides, together with the frequency of development of side‐effects. Both lines were effective and well tolerated, with significantly greater reduction of symptom and sign scores and higher overall patient satisfaction on the side receiving BTX‐A, an effect which lasted for a significantly longer duration on this side (4 months) as compared with the other side (1 month). In conclusion, intradermal BTX‐A at a dose of 100 units/palm is beneficial and well tolerated in chronic dry palmar eczema. Compared with topical steroid and emollients alone, its addition yielded superior efficacy that was longer lasting and more satisfactory to the patients, while exerting a steroid‐sparing effect.Keywords
This publication has 30 references indexed in Scilit:
- Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated reviewJournal of Cosmetic Dermatology, 2019
- Prevalence of C. botulinum and C. perfringens spores in food products available on Polish marketJournal of Veterinary Research, 2017
- New Uses of AbobotulinumtoxinA in AestheticsAesthetic Surgery Journal, 2017
- Botulinum Toxin Off-Label Use in Dermatology: A ReviewSkin Appendage Disorders, 2017
- Botulinum Toxin as a Pain Killer: Players and Actions in AntinociceptionToxins, 2015
- Guidelines for diagnosis, prevention and treatment of hand eczemaJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2015
- Visual Analogue Scale: Evaluation of the Instrument for the Assessment of PruritusActa Dermato Venereologica, 2012
- Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczemaContact Dermatitis, 2011
- Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skinBritish Journal of Dermatology, 2009
- The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliabilityBritish Journal of Dermatology, 2005